drugset / Trial / NCT00408083

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

NCT00408083

Phase 3 Completed 100 enrolled Bracco Diagnostics, Inc
RandomizedCrossoverQuadruple-blindDiagnostic

Summary

This is a double blind crossover study designed to compare two different gadolinium products given at the same dose to patients undergoing MRA assessment of lower legs for the evaluation of peripheral steno-occlusive disease.

Timeline

Start
2006-12
Primary completion
2008-11
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobenate dimeglumine Diagnostic / imaging agent 0.5 unknown
Comparator Gadopentetate dimeglumine Diagnostic / imaging agent 0.5 unknown